Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 22 Neoplasms 16 Leukemia, Myeloid, Acute 10 Ovarian Neoplasms 7 Neoplasm Metastasis 7 Lung Neoplasms 7 Lymphoma 6 Hematologic Neoplasms 6 Colorectal Neoplasms 6 Prostatic Neoplasms 5 Multiple Myeloma 5 Glioblastoma 5 Stomach Neoplasms 4 Leukemia 4 Fatigue 4 Carcinoma, Non-Small-Cell Lung 4 Vulvar Neoplasms 3 Uterine Cervical Neoplasms 3 Urinary Bladder Neoplasms 3 Triple Negative Breast Neoplasms 3 Sarcoma 3 Pancreatic Neoplasms 3 Pain 3 Myelodysplastic Syndromes 3 Motor Activity 3 Melanoma 3 Depression 3 Anxiety Disorders 3 Vaginal Neoplasms 2 Rectal Neoplasms 2

Interventions

Standard of Care 3 Self-Management 1 Pharmacists 1 Pharmaceutical Services 1 Palliative Care 1 Motivational Interviewing 1 Hypnosis 1 Historically Controlled Study 1 General Practitioners 1 Drug Delivery Systems 1 Cognitive Behavioral Therapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Medication Adherence × Palliative Care × Clear all

NCT04984850 2024-02-29

ON-BOARD

McGill University

Phase NA Completed

Medication Adherence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡